Fluorecare SARS-CoV-2 Antigen Testing is certified by QCMD

Through the international external quality assessment ( EQA ) contrast experiment, with excellent product performance,
fluorecare SARS-CoV-2 Antigen Testing is certified by QCMD.

The primary objective of QCMD 2022 SARS-CoV-2 Antigen Testing EQA is to assess the sensitivity of assays routinely
used for molecular detection of SARS-CoV-2 at clinically appropriate levels, near the limit of detection as well as the
specificity of assays in the presence of other human coronaviruses.